Coronavirus disease 2019 (COVID-19) is an ongoing worldwide pandemic infection. The exact incidence of disease re-infection or recurrence remains unknown. One particular at-risk population includes individuals with solid organ transplantation on immunosuppression. We present a case of COVID-19 re-infection in a chronically immunocompromised liver transplant patient. A 53-year-old female presented to the Emergency Department (ED) with nausea, vomiting, diarrhea, and myalgias. She was found to test positive for COVID-19. Her relevant medical history included liver transplantation on chronic immunosuppression. More recently, she had tested positive for COVID-19 approximately three months prior to this and was hospitalized at that time for encephalopathy and treated with remdesivir and convalescent plasma. She had subsequently recovered with negative COVID-19 testing in the interim. On the ED presentation with presumed re-infection, her disease was deemed to be mild with lack of severe symptoms or pulmonary involvement, and she was discharged with outpatient follow-up for monoclonal antibody infusion therapy. We describe a scenario of presumed COVID-19 re-infection in a liver transplant patient. To our knowledge, this is a rare event and has been reported internationally in only a handful of individuals. We surmise that immunosuppression could offer some protection from the inflammatory cascade of the initial disease process in COVID-19 given the relatively mild disease observed in our patient. On the other hand, a less robust immune response may decrease humoral immunity and leave patients at greater risk of re-infection. Further investigation is necessary to delineate COVID-19 disease re-infection versus relapse, especially in the setting of an immunocompromised state.
【저자키워드】 COVID-19, SARS-CoV-2, coronavirus, Immunosuppression, Transplant, Re-infection, 【초록키워드】 convalescent plasma, Coronavirus disease 2019, immune response, therapy, Hospitalized, knowledge, monoclonal antibody, Infection, solid organ transplantation, Remdesivir, risk, diarrhea, COVID-19 disease, Humoral immunity, COVID-19 testing, female, Patient, Liver transplantation, Immunocompromised, Mild, Encephalopathy, Follow-up, incidence, disease, liver, Emergency, myalgias, individual, worldwide pandemic, pulmonary involvement, nausea, vomiting, Department, positive, offer, inflammatory cascade, decrease, robust, initial, greater, tested, lack, include, reported, treated, less, individuals, discharged, severe symptom,